Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Abrdn Healthcare Investors

Abrdn Healthcare Investors (HQH) Stock Overview

Explore Abrdn Healthcare Investors’s financial performance, market position, analyst ratings, and future outlook.

HQH●NYSE
Financial ServicesAsset Management
$23.61
$0.22(0.94%)
U.S. Market opens in 7h 28m

Abrdn Healthcare Investors (HQH)

Meyka AI Score

Z

Key Financials

Market Cap1.3B
P/E Ratio12.79
EPS (TTM)$4.47
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$24.69
3 Months$25.43
1 Year Target$23.58

HQH Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Abrdn Healthcare Investors (NYSE: HQH) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Abrdn Healthcare Investors's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HQH on the NYSE shows an RSI of 57.65, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $23.58 for the NYSE listing.

Key metrics behind Abrdn Healthcare Investors's NYSE-traded stock include a P/E ratio of 12.79 and a market capitalization of 1.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of HQH on the NYSE.

Price Performance (NYSE: HQH)

1-Day Change
0.90%
5-Day Change
-1.99%
1-Month Change
9.77%
3-Month Change
21.90%
6-Month Change
20.65%
Year-to-Date (YTD) Change
24.60%
1-Year Change
45.86%
3-Year Change
42.43%
5-Year Change
-15.50%
All-Time (Max) Change
142.05%

Contact Information

https://www.teklacap.com
215 405 5700
1900 Market Street, Philadelphia, PA, 19103

Company Facts

IPO DateApr 23, 1987
CountryUS
Actively Trading

Frequently Asked Questions